To complement the existing treatment guidelines for all tumour types, ESMO organises
consensus conferences to focus on specific issues in each type of tumour. The 2nd ESMO …

… Certain relationships marked with a “U” are those for which no compensation was received;
those relationships marked with a “C” were compensated. For a detailed description of the …

Desmoid-type fibromatosis (DF) is a rare locally aggressive monoclonal proliferation of
myofibroblasts lacking metastatic capacity. It may be observed in nearly every part of the body. …

Background Prophylactic cranial irradiation reduces the incidence of brain metastasis in
patients with small-cell lung cancer. Whether this treatment, when given to patients in complete …

Malignant pleural mesothelioma (MPM) is a rare tumour but with increasing incidence and a
poor prognosis. In 2008, the European Respiratory Society/European Society of Thoracic …

Background Unlike for extremity sarcomas, the efficacy of radiotherapy for retroperitoneal
sarcoma is not established. The aim of this study was to evaluate the impact of preoperative …

Background Concurrent chemoradiotherapy is the standard of care in limited-stage small-cell
lung cancer, but the optimal radiotherapy schedule and dose remains controversial. The …

… Le Péchoux C … The members of the PCI committees were as follows: Secretariat (IGR)—C
Le Péchoux, A Dunant, A Laplanche, M Tarayre, N Bouvet-Forteau. Steering … Le Péchoux C …

Background Despite several randomised trials comparing radiotherapy alone with concomitant
radio-chemotherapy in patients with locally advanced non-small cell lung cancer (NSCLC…

OBJECTIVE: To evaluate the impact of surgery as first-line treatment on event-free survival (EFS)
of primary aggressive fibromatosis. PATIENTS AND METHODS: Treatments were …